Capability brief · 2026 edition

Biomanufacturing

The capacity to make with biology: fermentation, cell and gene production platforms, vaccine and biologics manufacture, and the bioprocess technology that turns biological designs into supply.

Contents

7 chapters

At a glance

指标
3
Nations rated
10
Leader
🇨🇳 CHN
Top rating
AAA
Related
8
发展
21

THE WHOLE BRIEF

Biomanufacturing Capability Profile 2026

PDF coming soon

GINC Indices

A summary here, the full index on its own site

Foundations

What this brief carries of its own

Foundations · Chapter 01

Definition

What this capability is, and how it is measured

The capacity to make with biology: fermentation, cell and gene production platforms, vaccine and biologics manufacture, and the bioprocess technology that turns biological designs into supply.

指标

  • Biologics manufacturing capacity
  • Vaccine production capacity
  • Fermentation capacity installed

Foundations · Chapter 02

History

Where the capability came from and how it has developed.

A history of Biomanufacturing will be published here. The developments below carry the record in the meantime.

Biomanufacturing的形成历程 →

GINC Indices · Chapter 04

National Capability

Which nations hold it, and how strongly.

占位

在该能力完成评级之前,这些评级仅为占位。

#国家评级
1ChinaAAA
2JapanAA
3South KoreaAA
4AustraliaA
5SingaporeA
6ItalyA
7SpainBBB
8SwitzerlandBBB
9FranceBB
10GermanyBB

GINC Indices · Chapter 05

Developments

The ledger of strategic events over time.

  • 地缘政治
  • 治理
  • 技术
  • 经济
  • 社会

历史发展

由早至晚
  1. c. 7000 BCE · about 9,000 years ago

    Villagers at Jiahu in China produced the earliest known fermented beverage

    Residues in pottery from the Yellow River valley show a drink made from rice, honey and fruit, evidence that using living organisms to manufacture a consumable product is a Neolithic technology.

  2. 1919 · 107 years ago

    Pfizer opened the first industrial fermentation plant for citric acid

    Using the mould Aspergillus niger, the process ended reliance on imported Italian citrus for citric acid and became the model for large-scale industrial fermentation of organic acids and, later, antibiotics.

  3. 1943 · 83 years ago

    US pharmaceutical manufacturers scaled penicillin production using deep-tank fermentation

    Submerged fermentation in large steel tanks, developed under wartime pressure, turned penicillin from a scarce laboratory extract into a mass-produced drug, establishing industrial fermentation methods still used for antibiotics.

  4. 1956 · 70 years ago

    Japanese researchers discovered a bacterium that made industrial amino acid fermentation possible

    Kyowa Hakko scientists isolated Corynebacterium glutamicum, enabling low-cost microbial production of glutamate and later lysine, and establishing Japan as a founder of the modern industrial fermentation industry.

  5. 1957 · 69 years ago

    Theodore Puck derived the Chinese hamster ovary cell line

    The cell line isolated at the University of Colorado became the standard host for manufacturing complex biologic drugs, and CHO cells are still used to produce most therapeutic antibodies today.

  6. 1973 · 53 years ago

    Herbert Boyer and Stanley Cohen demonstrated recombinant DNA technology

    Splicing foreign DNA into bacteria and having it replicate gave biomanufacturing its foundational tool, turning microorganisms into programmable production hosts for proteins they do not naturally make.

  7. 1975 · 51 years ago

    Georges Köhler and César Milstein invented the hybridoma technique for producing monoclonal antibodies

    Fusing antibody-producing cells with myeloma cells created a way to manufacture a single, uniform antibody indefinitely, the basis of the monoclonal antibody industry that now dominates biologic drug sales.

  8. 1982 · 44 years ago

    Genentech and Eli Lilly brought the first recombinant biologic drug to market

    Humulin, human insulin manufactured by genetically engineered bacteria, replaced insulin extracted from animal pancreases and proved that engineered microorganisms could manufacture a protein drug at commercial scale.

  9. 1995 · 31 years ago

    China became the world's largest producer of fermentation-derived antibiotics and bulk drug ingredients

    State-linked and private manufacturers built vast fermentation capacity for penicillin, vitamin and amino acid intermediates, making China the dominant global supplier of bulk pharmaceutical ingredients still relied on today.

  10. 2004 · 22 years ago

    NCBioImpact was established as a state-wide biomanufacturing training network

    NCBioImpact was set up in 2004 as a comprehensive state-wide training network for biomanufacturing skills. Such workforce initiatives matter because biomanufacturing depends on personnel trained in the specialised equipment and cell-culture techniques used to grow microbes, animal cells and plant cells.

  11. 2020 · 6 years ago

    mRNA vaccine manufacturers scaled a new biomanufacturing platform to billions of doses

    Pfizer-BioNTech and Moderna took lipid-nanoparticle mRNA production from laboratory scale to billions of doses within a year, establishing a manufacturing platform now being adapted for other diseases.

    • The WHO launched a technology transfer hub in South Africa to spread mRNA manufacturing know-how

近期发展

由新至旧
  1. October 2025 · 10 months ago

    China named biomanufacturing a strategic pillar for its next five-year plan

    Proposals discussed at the Communist Party's autumn plenum set biomanufacturing alongside other frontier sectors as a priority for the 2026 to 2030 planning period, continuing state support for fermentation and cell-culture capacity.

    • Shenzhen had already passed China's first dedicated biomanufacturing regulation
  2. April 2025 · last year

    Samsung Biologics brought its largest single biologics plant toward full operation

    Plant 5 at the company's Songdo bio campus added large-scale mammalian cell-culture capacity, reinforcing South Korea's position as host to the world's biggest contract biologics manufacturer by volume.

  3. 2025 · last year

    Fiocruz began domestic production of mRNA vaccine antigen

    Brazil's Bio-Manguinhos institute, using technology licensed through the WHO mRNA hub network, produced its first batches of locally made mRNA vaccine antigen, part of a wider Latin American push for manufacturing independence.

  4. 2025 · last year

    Afrigen Biologics took its self-developed mRNA vaccine into human trials

    The Cape Town firm, hub of the WHO-backed mRNA technology transfer programme, moved its reverse-engineered COVID-19 vaccine candidate into a Phase 1 trial, a step toward African vaccine manufacturing self-sufficiency.

  5. 2025 · last year

    WuXi Biologics expanded manufacturing outside China as US restrictions loomed

    Facing possible exclusion from US federal contracts under proposed legislation, the contract manufacturer continued building capacity in Singapore and Ireland to keep serving Western customers from outside mainland China.

    • The proposed BIOSECURE Act was the immediate driver
  6. December 2024 · 2 years ago

    Novo Nordisk took control of three former Catalent fill-finish plants

    Completion of Novo Holdings' acquisition of Catalent transferred sterile fill-finish sites to Novo Nordisk, adding capacity dedicated to easing the shortage of injectable GLP-1 weight-loss and diabetes drugs.

    • GLP-1 demand had outstripped fill-finish capacity industry-wide
  7. September 2024 · 2 years ago

    The US House Energy and Commerce Committee advanced the BIOSECURE Act

    The bill would bar federal agencies from contracting with named Chinese biomanufacturers, including WuXi Biologics and WuXi AppTec, citing national security concerns over reliance on Chinese-made biologics.

    • The measure was left out of the year-end defence authorisation bill
  8. August 2024 · 2 years ago

    India approved its BioE3 policy to build domestic biomanufacturing hubs

    The Cabinet-approved Biotechnology for Economy, Environment and Employment policy set out support for bio-based chemicals, bioplastics and biopharmaceuticals, aiming to build regional biomanufacturing hubs and cut import dependence.

  9. July 2024 · 2 years ago

    Ginkgo Bioworks cut roughly a third of its workforce

    The synthetic biology and foundry company restructured as pandemic-era biosecurity revenue fell away, narrowing its focus toward cell engineering services and away from broader platform ambitions.

  10. May 2024 · 2 years ago

    Florida banned the sale of cultivated meat

    The state became the first in the US to prohibit sale of lab-grown meat outright, a move other states followed, complicating the commercial path for cultivated-protein biomanufacturers.

时间线取自英文维基百科条目《Biomanufacturing》(CC BY-SA 4.0),这是 Factbase 为此参考的唯一来源。

GINC Indices · Chapter 06

Research

The nations that publish the most research in this capability

Source GINC Research Analytics, research.factbase.org.

research.ginc.org ↗

GINC Indices · Chapter 07

Patents

The nations where the most patent families in this capability began

Source GINC Patents, patents.ginc.org. A family is one invention, however many offices it was filed at; an international family was filed in more than one country.

patents.ginc.org ↗